KADSURENONE DISTINGUISHES BETWEEN DIFFERENT PLATELET-ACTIVATING-FACTOR RECEPTOR SUBTYPES ON MACROPHAGES AND POLYMORPHONUCLEAR LEUKOCYTES

被引：83

作者：

LAMBRECHT, G ^{[1
]}

PARNHAM, MJ ^{[1
]}

机构：

[1] A NATTERMANN & CIE GMBH,PHARMACOL RES,POB 350120,D-5000 COLOGNE 30,FED REP GER

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 1986年 / 87卷 / 02期

关键词：

D O I：

10.1111/j.1476-5381.1986.tb10816.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：287 / 289

页数：3

共 9 条

[1] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O
SCHILD, HO
[J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
[2] NOVEL EFFECTS OF 1-0-HEXADECYL-2-ACYL-SN-GLYCERO-3-PHOSPHORYLCHOLINE MEDIATORS ON HUMAN-LEUKOCYTE FUNCTION - DELINEATION OF THE SPECIFIC ROLES OF THE ACYL SUBSTITUENTS
GOETZL, EJ
DERIAN, CK
TAUBER, AI
VALONE, FH
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 94 (03) : 881 - 888
[3] PLATELET ACTIVATING FACTOR (PAF) INDUCES THE OXIDATIVE BURST IN MACROPHAGES
HARTUNG, HP
PARNHAM, MJ
WINKELMANN, J
ENGLBERGER, W
HADDING, U
[J]. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1983, 5 (02): : 115 - 121
[4] IMMUNIZATION OF DISSOCIATED SPLEEN CELL CULTURES FROM NORMAL MICE
MISHELL, RI
DUTTON, RW
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1967, 126 (03) : 423 - &
[5] OFLAHERTY JT, 1983, CLIN REV ALLERG, V1, P353
[6] PARNHAM MJ, 1983, INSERM S, V23, P187
[7] SHAW JO, 1981, J IMMUNOL, V127, P1250
[8] CHARACTERIZATION OF A PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST ISOLATED FROM HAIFENTENG (PIPER-FUTOKADSURA) - SPECIFIC-INHIBITION OF INVITRO AND INVIVO PLATELET-ACTIVATING FACTOR-INDUCED EFFECTS
SHEN, TY
HWANG, SB
CHANG, MN
DOEBBER, TW
LAM, MHT
WU, MS
WANG, X
HAN, GQ
LI, RZ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (03) : 672 - 676
[9] PA2 AND RECEPTOR DIFFERENTIATION - STATISTICAL-ANALYSIS OF COMPETITIVE ANTAGONISM
TALLARIDA, RJ
COWAN, A
ADLER, MW
[J]. LIFE SCIENCES, 1979, 25 (08) : 637 - 654

← 1 →